Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07568275 · ClinicalTrials.gov registry record · Early Phase 1
Comparison of Angiotensin II to Standard Dose Vasopressors on Change in Arterial Elastance
A Early Phase 1 study, sponsored by The Cleveland Clinic.
- Active
- Registry status
- Early Phase 1
- Development phase
- 30
- Enrollment target
NCT07568275 is a Early Phase 1 study that is active but no longer recruiting, run by The Cleveland Clinic. The registered enrollment target is 30 participants.
The verdict
NCT07568275, a Early Phase 1 study, is active but no longer recruiting, sponsored by The Cleveland Clinic.
- ACTIVE NOT RECRUITING
- Registry status
- Early Phase 1
- Development phase
- 30 participants
- Enrollment target
Study Summary
A study to see whether a medication called Angiotensin II works better than the routinely used medication to raise blood pressure in people with liver disease who are experiencing a serious drop in blood pressure. The investigators want to find out if Angiotensin II can help the heart and blood vessels work together more effectively than standard treatments.
Interventions
- DRUG Giapreza
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2024-11-15 |
| Est. Completion | 2028-01 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07568275
The ClinicalTrials.gov registry entry for NCT07568275 describes a study currently listed as active not recruiting, categorized as Early Phase 1. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The Cleveland Clinic, which has 688 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Giapreza is the first listed.
NCT07568275 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07568275 about?
NCT07568275 is a clinical study titled "Comparison of Angiotensin II to Standard Dose Vasopressors on Change in Arterial Elastance". A study to see whether a medication called Angiotensin II works better than the routinely used medication to raise blood pressure in people with liver disease who are experiencing a serious drop in blood pressure. The investigators want to find out if Angiotensin II can help the heart and blood ves...
What is the current status of trial NCT07568275?
This trial is currently active not recruiting. It is a Early Phase 1 study. The enrollment target is 30 participants. The study started on 2024-11-15. Estimated completion is 2028-01.
What interventions are being tested in trial NCT07568275?
The interventions under investigation include: Giapreza (DRUG).
Who is sponsoring clinical trial NCT07568275?
This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.